Global Sicca Syndrome (Sjogren) Market, By Type (Primary Sicca/Sjogren Syndrome, Secondary Sicca/Sjogren Syndrome, Others), Diagnosis (Blood Tests, Eye Tests, Imaging Tests, Biopsy, Others), Treatment (Medications, Surgery, Others), Route of Administration (Oral, Parenteral, Ocular, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others) – Industry Trends and Forecast to 2029.
Sicca Syndrome (Sjogren) Market Analysis and Size
The global sicca syndrome (Sjogren) market is expected to witness significant growth during the forecast period. The increase in the facilities for patients affected by rare diseases has directly impacted the sicca syndrome (Sjogren) market growth. Growing cases of dry eyes and dry mouth drives the sicca syndrome (Sjogren) market. Due to environmental pollution, increased contact lens usage and adoption of unhealthy lifestyle also boost the sicca syndrome (Sjogren) market growth. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global sicca syndrome (Sjogren) market in the forecast period 2022-2029. The expected CAGR of global sicca syndrome (Sjogren) market is tend to be around 14% in the mentioned forecast period. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Sicca syndrome is an autoimmune disorder characterized by dry eye and mouth. Sjogren syndrome causes immune system haywire and attack normal healthy cell instead of invading virus and bacteria. In this syndrome, white blood cells which protect us from germ, attack the gland that produces moisture and cannot produce tears and saliva.
Sicca Syndrome (Sjogren) Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Primary Sicca/Sjogren Syndrome, Secondary Sicca/Sjogren Syndrome, Others), Diagnosis (Blood Tests, Eye Tests, Imaging Tests, Biopsy, Others), Treatment (Medications, Surgery, Others), Route of Administration (Oral, Parenteral, Ocular, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
GlaxoSmithKline plc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Eli Lily and Company (U.S.), Pfizer Inc. (U.S.), Merck & Co., Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Novartis AG (Switzerland), Boehringer Ingelheim International Gmbh (Germany), Sanofi (France), Astrazeneca (U.K.), AbbVie Inc. (U.S.), Abbott (U.S.), Bayer AG (Germany), Johnson & Johnson Services, Inc. (U.S.)
|
|
Market Opportunities
|
|
Global Sicca Syndrome (Sjogren) Market Dynamics
Drivers
- Increase in Rheumatic Disorders
Rheumatic Disorders are on the rise worldwide. Sjogren’s syndrome is the second most common rheumatic disorder. It can affect individuals of any age but most commonly in elderly people. More women are affected by this disease as compared to men. The disorder can be of primary and secondary. Thus, it acts as a major driver in the market growth.
- Increasing Awareness of Healthcare Infrastructure
Another significant factor influencing the growth rate of sicca syndrome (Sjogren) market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aim to improve the healthcare infrastructure by increasing funding, which will further influence the market dynamics.
Opportunities
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for market growth for the sicca syndrome (Sjogren). To encourage researchers and pharmaceutical companies to develop novel medicines, the government is funding research and development (R&D) initiatives. Researchers such as Biogen Inc. and Bristol-Myers Squibb Company are now evaluating biological therapies for the treatment of Sjogren's syndrome.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified personnel who are unable to perform these treatments could curb the growth of the global sicca syndrome (Sjogren) market over a forecast period.
- High Cost
The huge expenditure required for the treatment processes surely hamper the market growth. Several market players make huge investment in installing new and advanced treatment procedures to faster the recovery process and in return the cost is increased.
This global sicca syndrome (Sjogren) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global sicca syndrome (Sjogren) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Sicca Syndrome (Sjogren) Market
Considering the present scenario, COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Its long-term repercussions are expected to influence industry growth during the forecast period.
The load on healthcare facilities and professionals was growing in tandem with the rapid increase in patient numbers. Many hospitals have decided to cancel or postpone procedures. The pandemic had a mixed influence on the sicca syndrome (Sjogren) market. The epidemic has put a strain on the treatment procedures overall. As a result of the lockdown and travel restrictions, the number of hospitals has decreased and countless drives have been cancelled around the world.
Global Sicca Syndrome (Sjogren) Market Scope
The global sicca syndrome (Sjogren) market is segmented on the basis of drug type, treatment type, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Primary Sicca/Sjogren Syndrome
- Secondary Sicca/Sjogren Syndrome
- Others
Diagnosis
- Blood Tests
- Eye Tests
- Imaging Tests
- Biopsy
- Others
Treatment
- Medications
- Surgery
- Others
Route of Administration
- Oral
- Parenteral
- Ocular
- Others
End-Users
- Hospitals
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacies
- Others
Sicca Syndrome (Sjogren) Market Regional Analysis/Insights
The global sicca syndrome (Sjogren) market is analysed and market size insights and trends are provided by drug type, treatment type, distribution channel and end-user as referenced above.
The major countries covered in the global sicca syndrome (Sjogren) market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the market in the forecast period due to the increased clinical trials going on Sjogren syndrome and the rise in epidemiological studies.
Asia-Pacific is considered to have the most lucrative period due to increased ophthalmic surgeries and number of generic drugs.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Sicca Syndrome (Sjogren) Market Share Analysis
The global sicca syndrome (Sjogren) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global sicca syndrome (Sjogren) market
Key players operating in the global sicca syndrome (Sjogren) market include:
- GlaxoSmithKline plc. (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Novartis AG (Switzerland)
- Eli Lily and Company (U.S.)
- Pfizer Inc. (U.S.)
- Merck & Co., Inc. (U.S.)
- Bristol-Myers Squibb Company (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Novartis AG (Switzerland)
- Boehringer Ingelheim International Gmbh (Germany)
- Sanofi (France)
- Astrazeneca (U.K.)
- AbbVie Inc. (U.S.)
- Abbott (U.S.)
- Bayer AG (Germany)
- Johnson & Johnson Services, Inc. (U.S.)
SKU-